Proton spectroscopic imaging in cerebral ischaemia. Where we stand and what can be expected.
Berkelbach van der Sprenkel
J W
JW
Department of Neurosurgery, University Hospital Utrecht, The Netherlands.
Knufman
N M
NM
van Rijen
P C
PC
Luyten
P R
PR
den Hollander
J A
JA
Tulleken
C A
CA
D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000098:blood supply*; D002545:Brain Ischemia / Q000175:diagnosis / Q000503:physiopathology*; D001931:Brain Mapping / Q000295:instrumentation; D002794:Choline / Q000378:metabolism; D004734:Energy Metabolism / Q000502:physiology*; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000295:instrumentation*; D002546:Ischemic Attack, Transient / Q000175:diagnosis / Q000503:physiopathology; D008279:Magnetic Resonance Imaging / Q000295:instrumentation*; D009682:Magnetic Resonance Spectroscopy / Q000295:instrumentation*; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000502:physiology*; D010725:Phosphocreatine / Q000378:metabolism; D010758:Phosphorus / Q000378:metabolism; D011522:Protons; D012039:Regional Blood Flow / Q000502:physiology
D018377:Neurotransmitter Agents; D011522:Protons; D010725:Phosphocreatine; D010758:Phosphorus; D001224:Aspartic Acid; C000179:N-acetylaspartate; D002794:Choline